[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help] 

Status: Not Logged In; Sign In

A $110B bubble on $500M earnings. History warns: Bubbles always burst.

Joy Behar says people like their show because they tell the truth, unlike "dragon believer" Joe Rogan.

Male Passenger Disappointed After Another Flight Ends Without A Stewardess Frantically Asking If Anyone Can Land The Plane

Could the Rapid Growth of AI Boost Gold Demand?

LOOK AT MY ASS!

Elon Musk Responds As British Government "Summons" Him To 'Disinformation' Hearing

MSNBC Contributor Panics Over Trump Nominating Bondi For AG: Dangerous Because Shes Competent

House passes dangerous bill that targets nonprofits, pro-Palestine groups

Navy Will Sideline 17 Support Vessels to Ease Strain on Civilian Mariners

Israel carries out field executions, massacres in north Gaza

AOC votes to back Israel Lobby's bogus anti-Semitism definition

Biden to launch ICE mobile app, further disrupting Trump's mass deportation plan: Report

Panic at Mar-a-Lago: How the Fake Press Pool Fueled Global Fear Until X Set the Record Straight

Donald Trumps Nominee for the FCC Will Remove DEI as a Priority of the Agency

Stealing JFK's Body

Trump plans to revive Keystone XL pipeline to solidify U.S. energy independence

ASHEVILLE UPDATE: Bodies Being Stacked in Warehouses & Children Being Taken Away

American news is mostly written by Israeli lobbyists pushing Zionist agenda

Biden's Missile Crisis

British Operation Kiss kill Instantly Skripals Has Failed to Kill But Succeeded at Covering Up, Almost

NASA chooses SpaceX and Blue Origin to deliver rover, astronaut base to the moon

The Female Fantasy Exposed: Why Women Love Toxic Love Stories

United States will NOT comply with the ICC arrest warrant for Prime Minister Netanyahu:

Mississippi’s GDP Beats France: A Shocking Look at Economic Policy Failures (Per Capita)

White House Refuses to Recognize US Responsibility for Escalation of Conflict in Ukraine

MAKE EDUCATION GREAT AGAIN!!

They will burn it with a "Peresvet" or shoot it down with a "hypersound"

NY Times: Could Trumps Return Pose a Threat to Climate and Weather Data?

Apples new AI-powered Siri?

Pepe Escobar: The BRICS Spirit Is Alive And Well In South Africa


Editorial
See other Editorial Articles

Title: Is Any Industry’s Interests More at Odds With Those of Taxpayers?
Source: [None]
URL Source: http://ycharts.com/analysis/story/i ... t_odds_with_those_of_taxpayers
Published: Feb 16, 2013
Author: http://ycharts.com/analysis/story/is_any
Post Date: 2013-02-16 08:36:31 by tom007
Keywords: None
Views: 94
Comments: 1

Is Any Industry’s Interests More at Odds With Those of Taxpayers? by Ed Silverman February 15, 2013

0 0 epSos.de

Just hours after President Barack Obama revived a proposal to require drugmakers to provide Medicare with the same sort of discounts that are given to Medicaid, a new analysis claims taxpayers could save even more money if the US government directly negotiates prescription drug prices with the pharmaceutical industry.

In his State of the Union address this week, Obama called for reforming Medicare but was not specific. However, the U.S. Department of Health & Human Services Office of the Inspector General estimates that Medicare Part D gets a 19 percent discount on drugs, compared with a 45 percent discount for Medicaid. By realigning the discounts, the White House estimates about $156 billion could be saved over a decade.

However, the federal government could save anywhere from $230 billion to $541 billion over the next 10 years if the government were to negotiate Medicare drug prices directly with the pharmaceutical industry. And state governments could save from $31 billion to $72 billion, while consumers could save from $48 billion to $112 billion over the same period, according to the analysis by the Center for Economic and Policy Research.

Savings like those, of course, would mean a less-profitable pharmaceutical industry – including Pfizer (PFE), Novartis (NVS), Merck (MRK), GlaxoSmithKline (GSK), Sanofi (SNY) and Eli Lilly (LLY) -- and stock prices would be expected to fall substantially. PFE Market Cap Chart

PFE Market Cap data by YCharts

“It’s ridiculous for Medicare to be paying drug companies two and three times as much money for drugs as other countries at a time when we are cutting essential programs,” says Dean Baker, co-director of CEPR, which is a nonprofit think tank, and author of the analysis, in a statement. “This fix alone would go far towards hitting anyone’s deficit target.”

The rationale for the projected savings is that other countries that negotiate prescription drug prices directly with drugmakers have lower costs. For instance, the CEPR cites per capita spending in Canada, where costs per person are 72 percent lower than in the US. Similarly, costs are 39 percent lower in the United Kingdom and 34 percent lower in Denmark (read more here).

To read the remainder of this article, go to Pharmalot.

Ed Silverman, a contributing editor of YCharts, is the founder and editor of Pharmalot. He previously reported on the pharmaceutical industry and other business topics for the Star-Ledger of New Jersey, New York Newsday and Investor’s Business Daily. He can be reached at editor@ycharts.com. Featured Coverage

Apple Guy Reaches For the Storm Windows at JC Penney: Bigger Revolver, Employee Sniping Only $688 Million to Make Merck’s Vytorin Mess Go Away? Seems Almost Cheap How a Fund Manager Says Goodbye to a Winning Stock Hey, People Who Pushed Avon Shares up 22% This Week: It’s Still the Door-to-Door Business Why Heinz Deal Doesn’t Rule Out Bigger Acquisition by Buffett Not-So-Epic: Apple’s Recent Stock Plunge, in Context Shouldn't the Google of China Be Growing Faster Than Google? Happy Valentine: Margins Threatened at Chocolate Makers Hershey and Mondelez? Odd, This: Big Pharma On Losing End of Pricing Dispute A Drumbeat Against Soda Pop? Are Coke and Pepsi Shares Vulnerable? $176,000 or $295,00 a Year: Bizarre World of Orphan Drugs The Bull Case for Under Armour Stock -- and its New Gadget You Think Apple’s Swoon is Epic? Two Weirdly-Valued Stocks: If You Ignored Company Names, What Would You Think? Judge to Bristol-Myers: Patent on $1.4 Billion Hepatitis-B Treatment Invalid; Teva to Benefit Hewlett-Packard Stock: What a Handful of Big Buyers See Fees Matter: We Show Off Low-Cost ETFs That Undercut Mutual Fund Expenses Which New Consumer Payments Technology Will Prevail? Why It Matters Little to Visa, MasterCard FDA Decision on Diabetes Drug Hurts Novo Nordisk, Helps Sanofi McDonald’s Savior Jim Skinner Chairs the Walgreen Board: If Only He Were CEO

Other Resources

Reuters.com Bloomberg.com CNBC.com Forbes.com MarketWatch.com

TheStreet.com FT.com StockTwits.com Economist.com WSJ.com

Post Comment   Private Reply   Ignore Thread  


TopPage UpFull ThreadPage DownBottom/Latest

#1. To: tom007 (#0)

However, the federal government could save anywhere from $230 billion to $541 billion over the next 10 years if the government were to negotiate Medicare drug prices directly with the pharmaceutical industry. And state governments could save from $31 billion to $72 billion, while consumers could save from $48 billion to $112 billion over the same period, according to the analysis by the Center for Economic and Policy Research.

If you think that's good money just think how much we'd save if they completely dismantled it.

Calling Ron Paul an isolationist is like calling your neighbor a hermit because he doesn't come over and break your window - unknown

I WITHDRAW MY CONSENT!
Any perceived compliance with unconstitutional “laws” or orders put forth by government employees is NOT recognition of their authority; it is simply the result of carefully calculated submission to an entity exhibiting superior firepower.

F.A. Hayek Fan  posted on  2013-02-16   9:49:44 ET  Reply   Trace   Private Reply  


TopPage UpFull ThreadPage DownBottom/Latest


[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help]